news
The Robotic Breakthrough That Could Help Stroke Survivors Reclaim Their Stride
Primary tabs
Crossing a room shouldn’t feel like a marathon. But for many stroke survivors, even the smallest number of steps carries enormous weight. Each movement becomes a reminder of lost coordination, muscle weakness, and physical vulnerability.
A team of Georgia Tech researchers wanted to ease that struggle, and robotic exoskeletons offered a promising path. Their findings point to a simple but powerful shift: exoskeletons that adapt to people, rather than forcing people to adapt to the machine. Using artificial intelligence (AI) to learn the rhythm of patients’ strides in real time, the team showed how these devices can reduce strain and increase efficiency. They also demonstrated how the technology can help restore confidence for stroke survivors.
The Robot Finds the Rhythm
A robotic exoskeleton is a wearable device that helps people move with mechanical support. Traditional exoskeletons require endless manual adjustments — turning knobs, calibrating settings, and tweaking controls.
“It can be frustrating, even nearly impossible, to get it right for each person,” said Aaron Young, associate professor in the George W. Woodruff School of Mechanical Engineering. “With AI, the exoskeleton figures out the mapping itself. It learns the timing of someone’s gait through a neural network, without an engineer needing to hand-tune everything.”
The software monitors each step, instantly updates, and fine-tunes the support it provides. Over time, the exoskeleton aligns its movements with the unique gait of the person wearing it. In this study, the research team used a hip exoskeleton, which provides torque at the hip joint — in other words, adding power to help stroke survivors walk or move their legs more easily.
Taking Smarter Steps
Walking after a stroke can be tough and unpredictable. A patient’s stride can change from one day to the next, and even from one step to the next. Most exoskeletons aren’t built for that kind of variation. They are designed around the steady, even gait of healthy young adults, which can leave stroke survivors feeling more unsteady than supported.
Young’s breakthrough, detailed in IEEE Transactions on Robotics, is a neural network — a type of AI that learns patterns much like the human brain does. Sensors at the hip pick up how someone is moving, and the network translates those signals into just the right boost of power to support each step. It quickly figures out a person’s unique walking pattern. But lead clinician Kinsey Herrin said the AI’s learning doesn’t stop there. It keeps adjusting as the patient walks, so the exoskeleton can stay in sync even during stride shifts.
“The speed really surprised us,” Young said. “In just one to two minutes of walking, the system had already learned a person’s gait pattern with high accuracy. That’s a big deal, to adapt that quickly and then keep adapting as they move.”
Tests showed the system was far more accurate than the standard exoskeleton. It reduced errors in tracking stroke patients’ walking patterns by 70%.
Young emphasized that this research is about more than metrics. “When you see someone able to walk farther without becoming exhausted, that’s when you realize this isn’t just about robotics — it’s about giving people back a measure of independence,” he said.
Adapting Anywhere
Every exoskeleton comes with its own set of sensors, so the data they collect can look completely different from one device to the next. A neural network trained on one machine often stumbles when it’s moved to another. To get around that, Young’s team designed software that works like a universal adapter plug — no matter what device it’s connected to, it converts the signals into a form the AI can use. After just 10 strides of calibration, the system cut error rates by more than 75%.
“The goal is that someone could strap on a device, and, within a minute, it feels like it was built just for them,” Young said.
A Step Toward the Future
While the study centered on stroke survivors, the implications are far broader. The same adaptive approach could support older adults coping with age-related muscle weakness, people with conditions like Parkinson’s or osteoarthritis, or even children with neurological disabilities.
Young and his team are now running clinical trials to measure how well the AI-powered exoskeleton supports people in a wide range of everyday activities.
“There’s no such thing as an ‘average’ user,” Young said. “The real challenge is designing technology that can adapt to the full spectrum of human mobility.”
If Georgia Tech’s exoskeleton can rise to that challenge, the promise goes well beyond the lab. It could mean a world where technology doesn’t just help people walk — it learns to walk with them.
Inseung Kang, who holds a B.S., M.S., and Ph.D. from Georgia Tech, is the paper’s lead author and now an assistant professor of mechanical engineering at Carnegie Mellon University. He explained that the real promise is in what comes next.
“We’ve developed a system that can adjust to a person’s walking style in just minutes. But the potential is even greater. Imagine an exoskeleton that keeps learning with you over your lifetime, adjusting as your body and mobility change. Think of it as a robot companion that understands how you walk and gives you the right assistance every step of the way.”
Aaron Young is affiliated with Georgia Tech’s Institute for Robotics and Intelligent Machines.
This research was primarily funded by a grant (DP2HD111709-01) from the National Institutes of Health New Innovator Award Program. Georgia Tech researchers have created the first lung-on-a-chip with a functioning immune system, allowing it to respond to infections much like a real human lung. The breakthrough, published in Nature Biomedical Engineering, provides a more accurate way to study diseases, test therapies, and reduce reliance on animal models. With potential applications in conditions from influenza to cancer, the technology opens the door to personalized medicine that predicts how individual patients will respond to treatment.
Status
- Workflow Status:Published
- Created By:mazriel3
- Created:09/18/2025
- Modified By:Laurie Haigh
- Modified:09/18/2025